Covance Is Now Labcorp Drug Development

We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.

Learn More


Incorporating the Patient Voice to Improve Ulcerative Colitis Recruitment

The exact cause of ulcerative colitis (UC) is still unknown, but approximately 700,000 people in the United States suffer from this chronic, lifelong disease that causes inflammation in the large intestine. A wide range of treatment options are available, but drug development sponsors are seeking additional ways to control inflammation, achieve remission and address relapses.

Filed In

Autoimmune & Inflammatory
Clinical Trials
Design & Optimization
Mgmt Monitoring & RBM
Mgmt Monitoring & RBM
Patient Recruitment
Stage (Late, PhIIb-III)